The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
about
Gastroesophageal reflux disease in COPD: links and risksPositioning new pharmacotherapies for COPDHealth and social impacts of COPD and the problem of under-diagnosisSystemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patientsCorticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseImmune Dysfunction in Patients with Chronic Obstructive Pulmonary DiseaseEvaluating Comparative Effectiveness Research Priorities for Care Coordination in Chronic Obstructive Pulmonary Disease: A Community-Based eDelphi StudyUsing Persuasive Technology to Increase Physical Activity in People With Chronic Obstructive Pulmonary Disease by Encouraging Regular Walking: A Mixed-Methods Study Exploring Opinions and PreferencesHuman β-defensin-2 production upon viral and bacterial co-infection is attenuated in COPD.The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece.Application of Fuzzy Delphi in the Selection of COPD Risk Factors among Steel Industry Workers.Self-reported occupational noise may be associated with prevalent chronic obstructive pulmonary disease in the us general populationTime to adapt exercise training regimens in pulmonary rehabilitation--a review of the literature.Preventing COPD exacerbations: new options for a crucial and growing problemQuality of life and its association with direct medical costs for COPD in urban China.Use of predictive algorithms in-home monitoring of chronic obstructive pulmonary disease and asthma: A systematic review.Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics.COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare membersCOPD exacerbation care bundle improves standard of care, length of stay, and readmission rates.Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD)Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four citiesPharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients.Trend of cost and utilization of COPD medication in KoreaThe pharmacological cost of COPD during Greek economic crisis.Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis.Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.Characteristics of COPD Patients Using United States Emergency Care or HospitalizationChronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.Trends in Outcomes, Financial Burden, and Mortality for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010.Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease.Overdiagnosis of COPD in hospitalized patients.Comparative Response of Brain to Chronic Hypoxia and Hyperoxia.Pain problems for patients with mild and moderate chronic obstructive pulmonary disease - a community-based study in Shanghai.Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.Web-based Health Information Seeking and eHealth Literacy among Patients Living with Chronic Obstructive Pulmonary Disease (COPD).Insights from Australians with respiratory disease living in the community with experience of self-managing through an emergency department 'near miss' for breathlessness: a strengths-based qualitative study.Estimating the extent and economic impact of under and overdiagnosis of chronic obstructive pulmonary disease in primary care.Medical Care Costs Associated with Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-analysis.
P2860
Q26782475-3920B90A-3EC9-421D-BE68-83CD35F63A0DQ26798659-0D946DAE-A89A-4E70-9FB6-0E17CA2377B6Q26864108-C9D05A0B-E4EE-4301-8E16-FDFF2F2D8811Q27010596-7065C972-C0BB-4919-B174-3419ADAABF4BQ27023118-666EBD53-42FA-4E2E-B60B-15DDB3444AF9Q28083093-D6ABEC8F-7AFB-4F85-9DDC-A93F5139F7E2Q30361604-6FDB232B-7A53-4592-AFB8-FF0ED3E84F95Q33639851-E01A74FB-6417-4CE4-A524-618C67CF42C6Q33657752-10E32E09-E451-4123-942D-57F2889F96A9Q33703952-A2D5EB3B-1244-49C2-BA45-C214F20A71F0Q33806457-E92B8CAF-204A-4173-8589-6B5578DD9CFCQ33882666-0707D41D-4DE6-47D7-9A56-17C75044FB31Q34524905-3EEF9A23-3D84-48E0-AEFE-9B6B2EF50E69Q35149776-96585D24-442D-489C-9037-66FDAD8C4CAAQ35601175-290223AC-9F3E-40AB-927F-72BCAC2CA663Q35995056-D376EA70-EC91-4A0C-91F7-13ED21849A83Q36207526-CAF710B3-0735-4140-8E8A-353C7FA165AFQ36473543-AA15B426-F1C6-4750-927D-A1EF40EE4F2CQ36710167-55E7BA33-A305-4509-BF8E-95D65E970068Q37012197-0EC9F906-E0D3-4308-A30F-B58D1E9C389FQ37099911-FB8D783A-ABD2-4A9C-B0B6-385B6A3EEA36Q37365503-CCA125BC-EA59-42F1-9ECE-E35EB647D5A7Q37372207-DF9D6312-9686-4807-B5C2-6D03403ADBF9Q37530848-0708C07A-7760-4F4B-ABC3-C15ED04F6EFEQ37626470-1E078A66-F36F-4636-BD90-77748F6B02EFQ37701943-3ADD4B67-7D81-4491-B8FA-A03B6C00C728Q38598991-F6821B89-65B7-41BD-80D9-B3A339A78886Q38604642-96EED692-ACF6-4730-A939-BEF4DB510C37Q38987300-613F54C9-AA7B-4DD8-9459-0889DBB63D2DQ39599267-BA7C72FC-C5AF-4160-852D-805426BD7F35Q40235118-7F49800F-6075-41B5-8581-6119CD3FFB9BQ41037310-430378DF-39DA-44C9-97B5-2B0F858F9595Q41475801-6A405BC0-C25C-4456-BAAE-3CD3EB488733Q41660890-385E886E-91E1-4A08-9FA6-167CEC908384Q41867819-DFDCF22C-A164-426A-85EB-FB8F54D2D86AQ43456772-6A8BFDE1-F9FD-42DA-A7CD-C3D752B79AE0Q45182538-AB9521DA-CF03-4383-AC34-3376949C85E0Q46184373-1DE7003C-B854-4F61-A0D2-2C2E5B7C64DCQ47133161-BA8360CD-91F4-4702-B2E2-693C6FAFFD6FQ47188529-2FFD6394-F104-4278-8FFF-B8138592671D
P2860
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
@en
type
label
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
@en
prefLabel
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
@en
P2093
P2860
P356
P1476
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
@en
P2093
Anthony J Guarascio
Christopher K Finch
Shauntá M Ray
Timothy H Self
P2860
P304
P356
10.2147/CEOR.S34321
P407
P577
2013-06-17T00:00:00Z